Correlation Between SunLink Health and Neuropace

Can any of the company-specific risk be diversified away by investing in both SunLink Health and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SunLink Health and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SunLink Health Systems and Neuropace, you can compare the effects of market volatilities on SunLink Health and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SunLink Health with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of SunLink Health and Neuropace.

Diversification Opportunities for SunLink Health and Neuropace

-0.36

Correlation Coefficient

SunLink Health  Neuropace

Very good diversification

The 3 months correlation between SunLink and Neuropace is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding SunLink Health Systems and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and SunLink Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SunLink Health Systems are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of SunLink Health i.e., SunLink Health and Neuropace go up and down completely randomly.

Pair Corralation between SunLink Health and Neuropace

Considering the 90-day investment horizon SunLink Health Systems is expected to under-perform the Neuropace. But the stock apears to be less risky and, when comparing its historical volatility, SunLink Health Systems is 1.37 times less risky than Neuropace. The stock trades about -0.01 of its potential returns per unit of risk. The Neuropace is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  792.00  in Neuropace on August 30, 2024 and sell it today you would earn a total of  233.00  from holding Neuropace or generate 29.42% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

SunLink Health Systems  vs.  Neuropace

SunLink Health Systems

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days SunLink Health Systems has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, SunLink Health is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Neuropace

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with SunLink Health and Neuropace

The main advantage of trading using opposite SunLink Health and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SunLink Health position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.

The idea behind SunLink Health Systems and Neuropace pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.